United Laboratories International Holdings Ltd
HKEX:3933
United Laboratories International Holdings Ltd?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
7.9247
16.64
|
Price Target |
|
We'll email you a reminder when the closing price reaches HKD.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
3M Co
NYSE:MMM
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
What unique competitive advantages
does United Laboratories International Holdings Ltd hold over its rivals?
What risks and challenges
does United Laboratories International Holdings Ltd face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of United Laboratories International Holdings Ltd.
Provide an overview of the primary business activities
of United Laboratories International Holdings Ltd.
What unique competitive advantages
does United Laboratories International Holdings Ltd hold over its rivals?
What risks and challenges
does United Laboratories International Holdings Ltd face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for United Laboratories International Holdings Ltd.
Provide P/S
for United Laboratories International Holdings Ltd.
Provide P/E
for United Laboratories International Holdings Ltd.
Provide P/OCF
for United Laboratories International Holdings Ltd.
Provide P/FCFE
for United Laboratories International Holdings Ltd.
Provide P/B
for United Laboratories International Holdings Ltd.
Provide EV/S
for United Laboratories International Holdings Ltd.
Provide EV/GP
for United Laboratories International Holdings Ltd.
Provide EV/EBITDA
for United Laboratories International Holdings Ltd.
Provide EV/EBIT
for United Laboratories International Holdings Ltd.
Provide EV/OCF
for United Laboratories International Holdings Ltd.
Provide EV/FCFF
for United Laboratories International Holdings Ltd.
Provide EV/IC
for United Laboratories International Holdings Ltd.
Show me price targets
for United Laboratories International Holdings Ltd made by professional analysts.
What are the Revenue projections
for United Laboratories International Holdings Ltd?
How accurate were the past Revenue estimates
for United Laboratories International Holdings Ltd?
What are the Net Income projections
for United Laboratories International Holdings Ltd?
How accurate were the past Net Income estimates
for United Laboratories International Holdings Ltd?
What are the EPS projections
for United Laboratories International Holdings Ltd?
How accurate were the past EPS estimates
for United Laboratories International Holdings Ltd?
What are the EBIT projections
for United Laboratories International Holdings Ltd?
How accurate were the past EBIT estimates
for United Laboratories International Holdings Ltd?
Compare the revenue forecasts
for United Laboratories International Holdings Ltd with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of United Laboratories International Holdings Ltd and its key competitors using the latest financial data.
Compare historical revenue growth rates
of United Laboratories International Holdings Ltd against its competitors.
Analyze the profit margins
(gross, operating, and net) of United Laboratories International Holdings Ltd compared to its peers.
Compare the P/E ratios
of United Laboratories International Holdings Ltd against its peers.
Discuss the investment returns and shareholder value creation
comparing United Laboratories International Holdings Ltd with its peers.
Analyze the financial leverage
of United Laboratories International Holdings Ltd compared to its main competitors.
Show all profitability ratios
for United Laboratories International Holdings Ltd.
Provide ROE
for United Laboratories International Holdings Ltd.
Provide ROA
for United Laboratories International Holdings Ltd.
Provide ROIC
for United Laboratories International Holdings Ltd.
Provide ROCE
for United Laboratories International Holdings Ltd.
Provide Gross Margin
for United Laboratories International Holdings Ltd.
Provide Operating Margin
for United Laboratories International Holdings Ltd.
Provide Net Margin
for United Laboratories International Holdings Ltd.
Provide FCF Margin
for United Laboratories International Holdings Ltd.
Show all solvency ratios
for United Laboratories International Holdings Ltd.
Provide D/E Ratio
for United Laboratories International Holdings Ltd.
Provide D/A Ratio
for United Laboratories International Holdings Ltd.
Provide Interest Coverage Ratio
for United Laboratories International Holdings Ltd.
Provide Altman Z-Score Ratio
for United Laboratories International Holdings Ltd.
Provide Quick Ratio
for United Laboratories International Holdings Ltd.
Provide Current Ratio
for United Laboratories International Holdings Ltd.
Provide Cash Ratio
for United Laboratories International Holdings Ltd.
What is the historical Revenue growth
over the last 5 years for United Laboratories International Holdings Ltd?
What is the historical Net Income growth
over the last 5 years for United Laboratories International Holdings Ltd?
What is the current Free Cash Flow
of United Laboratories International Holdings Ltd?
Discuss the annual earnings per share (EPS)
trend over the past five years for United Laboratories International Holdings Ltd.
P/B
Price to Book Value
Price to Book Value (P/B) ratio is a valuation multiple that measures the market's valuation of a company relative to its book value. The P/B ratio is only considered useful in practice when applied to capital-intensive businesses.
Market Cap | P/B | ||||
---|---|---|---|---|---|
HK |
U
|
United Laboratories International Holdings Ltd
HKEX:3933
|
25.8B HKD | 1.7 | |
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
699.5B USD | 49.3 |
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP | 583.1 |
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
368.8B USD | 5.2 |
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
1.9T DKK | 13.4 |
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
208.7B CHF | 7.1 |
|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
167.6B GBP | 5.3 |
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
186.3B CHF | 5.2 |
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
206.3B USD | 4.6 |
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
162.4B USD | -39.3 |
|
FR |
![]() |
Sanofi SA
PAR:SAN
|
119.8B EUR | 1.5 |
|
HK |
U
|
United Laboratories International Holdings Ltd
HKEX:3933
|
Average P/B:
67.6
1.7
|
|
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
49.3
|
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
583.1
|
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
5.2
|
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
13.4
|
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
7.1
|
|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
5.3
|
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
5.2
|
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
4.6
|
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
Negative Multiple: -39.3 |
|
FR |
![]() |
Sanofi SA
PAR:SAN
|
1.5
|
|
P/B Forward Multiples
Forward P/B multiple is a version of the P/B ratio that uses forecasted equity for the P/B calculation. 1-Year, 2-Years, and 3-Years forwards use equity forecasts for 1, 2, and 3 years ahead, respectively.